Your browser doesn't support javascript.
loading
IL-33 Is a Negative Regulator of Vaccine-Induced Antigen-Specific Cellular Immunity.
O'Grady, Katie; Hearnden, Claire C H; Bento, Dulce; Oleszycka, Ewa; Andersen, Peter; Muñoz-Wolf, Natalia; Lavelle, Ed C.
Affiliation
  • O'Grady K; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland.
  • Hearnden CCH; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland.
  • Bento D; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland.
  • Oleszycka E; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland.
  • Andersen P; Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen 2300s, Denmark.
  • Muñoz-Wolf N; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland.
  • Lavelle EC; Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, D02R590, Ireland; lavellee@tcd.ie.
J Immunol ; 202(4): 1145-1152, 2019 02 15.
Article in En | MEDLINE | ID: mdl-30642984
ABSTRACT
The cytokine IL-33 is a well-established inducer of Th2 responses. However, roles for IL-33 in promoting CD8, Th1, and T regulatory cell responses have also emerged. In this study, the role of IL-33 as a regulator of particulate vaccine adjuvant-induced Ag-specific cellular immunity was investigated. We found that polymeric nanoparticles surpassed alum in their ability to enhance Ag-specific CD8 and Th1 responses. IL-33 was a potent negative regulator of both CD8+ T cell and Th1 responses following i.m. vaccination with Ag and nanoparticles, whereas the cytokine was required for the nanoparticle enhancement in Ag-specific IL-10. In contrast to the effect on cellular immunity, Ab responses were comparable between vaccinated wild-type and IL-33-deficient mice. IL-33 did not compromise alum-induced adaptive cellular immunity after i.m. vaccination. These data suggest that IL-33 attenuates the induction of cellular immune responses by nanoparticulate adjuvants and should be considered in the rational design of vaccines targeting enhanced CD8 and Th1 responses.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Interleukin-33 / Immunity, Cellular / Antigens Limits: Animals Language: En Journal: J Immunol Year: 2019 Document type: Article Affiliation country: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Interleukin-33 / Immunity, Cellular / Antigens Limits: Animals Language: En Journal: J Immunol Year: 2019 Document type: Article Affiliation country: Ireland